Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

University Of Porto
Sponsor

University Of Porto

Portugal Alameda Professor Hernani Monteiro, 4200-319 Porto, Portugal

About the sponsor

Research activity is centered on heart failure with reduced ejection fraction, with attention to patients who may also fall within the broader heart failure with mildly reduced ejection fraction spectrum.

  • Heart failure with reduced ejection fraction
  • Heart failure with mildly reduced ejection fraction
  • Cardiovascular disease

The clinical focus includes treatment strategies relevant to symptomatic cardiac dysfunction and optimization of guideline-based heart failure care.

About Specializations

University Of Porto runs clinical trials in conditions such as Heart failure with reduced ejection fraction, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Heart failure with reduced ejection fraction

Not recruiting
Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:University Of Porto

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.